WallStreetZenWallStreetZen

NASDAQ: MLYS
Mineralys Therapeutics Inc Stock Ownership - Who owns Mineralys Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Mineralys Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David Malcom RodmanChief Medical Officer2025-10-1510,369$43.01
$445.98kSell
Adam Scott LevyCFO and Secretary2025-10-137,366$41.90
$308.65kSell
Jon CongletonChief Executive Officer2025-10-1313,548$42.63
$577.55kSell
Jon CongletonChief Executive Officer2025-10-131,552$43.03
$66.78kSell
Adam Scott LevyCFO and Secretary2025-10-133,392$42.26
$143.33kSell
David Malcom RodmanChief Medical Officer2025-09-159,302$35.90
$333.94kSell
David Malcom RodmanChief Medical Officer2025-09-152,065$36.48
$75.32kSell
Ra Capital Management LPDirector2025-09-041,176,470$25.50
$30.00MBuy
Srinivas AkkarajuDirector2025-09-04588,235$25.50
$15.00MBuy
David Malcom RodmanChief Medical Officer2025-08-1311,365$12.93
$146.98kSell

1 of 5

MLYS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MLYS insiders and whales buy or sell their stock.

MLYS Shareholders

What type of owners hold Mineralys Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Srinivas Akkaraju17.10%11,338,067$452.39MInsider
Samsara Biocapital GP LLC16.22%10,749,832$428.92MInsider
Brian Taylor Slingsby13.43%8,903,838$355.26MInsider
Catalys Pacific LLC13.43%8,903,838$355.26MInstitution
Ra Capital Management LP9.27%6,147,280$245.28MInstitution
Samsara Biocapital LLC8.56%5,674,916$226.43MInstitution
Ra Capital Management LP5.63%3,734,458$149.00MInsider
Hbm Healthcare Investments Cayman Ltd4.85%3,218,106$128.40MInsider
Sr One Capital Management LP4.72%3,127,933$124.80MInstitution
Blackrock Inc4.67%3,097,760$123.60MInstitution

1 of 3

MLYS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MLYS62.77%37.23%Net BuyingNet Buying
BEAM86.56%13.44%Net SellingNet Selling
TVTX63.43%36.57%Net SellingNet Selling
RXRX71.45%16.05%Net SellingNet Selling
FOLD66.49%33.51%Net SellingNet Selling
View Top Biotech Stocks

Mineralys Therapeutics Stock Ownership FAQ

Who owns Mineralys Therapeutics?

Mineralys Therapeutics (NASDAQ: MLYS) is owned by 99.08% institutional shareholders, 58.77% Mineralys Therapeutics insiders, and 0.00% retail investors. Srinivas Akkaraju is the largest individual Mineralys Therapeutics shareholder, owning 11.34M shares representing 17.10% of the company. Srinivas Akkaraju's Mineralys Therapeutics shares are currently valued at $459.87M.

If you're new to stock investing, here's how to buy Mineralys Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.